Andreas Strüngmann

From Wikipedia, the free encyclopedia

You have new messages (last change).

Andreas Strüngmann (1950-) founded generic drug maker Hexal AG ($1.6 billion sales during 2004) in 1986. In February 2005, he and his brother sold Hexal and their 67.7% of U.S. Eon Labs to Novartis for $7.5 billion.

[edit] See also

[edit] External links

 This business-related biographical article is a stub. You can help Wikipedia by expanding it.
Retrieved from "http://en.wikipedia.org../../../a/n/d/Andreas_Str%C3%BCngmann_4e76.html"